OBJECTIVE: Solid pseudopapillary tumor (SPT) of the pancreas is an extremely rare primary tumor in the pediatric age group. It has a low malignant potential and the prognosis is good if radical resection of the tumor is performed. Local recurrence and distant metastasis has only rarely been reported following incomplete resection.
S olid pseudopapillary tumor (SPT) is one of the rarely seen primary tumors of the pancreas. In all age groups they constitute 2-3% of all primary pancreatic tumors [1] . They are more frequently seen in the second, and third decades of life, and in female children [2] . It was firstly defined by Frantz in the year 1959, and it was termed as papillary cystic tumor, solid cystic tumor, Frantz' s tumor [3] . In the year 1996, the World Health Organization designated the term "solid pseudopapillary tumor" for this tumor [4] . It has lower malignancy potential, and its prognosis is very good after radical resection. However local recurrence, and also distant metastasis were reported following incomplete resection [5] . Its pathogenesis has not been clarified completely yet. Some authors claimed that this tumor has a hormonal origin, some others advocated that these tumors originate from ductal, acinar or primitive cells. Characteristically these tumors are bulky, however they are asymptomatic or have mild symptoms [6] .
In this study, clinical characteristics, results of pathophysiologic, immunohistochemical analyses, and surgical treatment have been ivestigated.
MATERIALS AND METHODS
In this study the files of 6 patients who were diagnosed as SPT based on the histopathological examination of the specimen in Erciyes University Faculty of Medicine, Hospital of Children' s Health and Diseases between the years 2010, and 2017 were retrospectively screened. Approval of Ethics Committee of Erciyes University Faculty of Medicine was obtained. Demographic characteristics, location, and size of the tumor, diagnostic methods, immunohistochemical staining characteristics, medical, annd surgical treatments applied were recorded. For immunohistochemical staining, beta-catenin, keratin, chromogranin, CD56, synaptophysin, vimentin, CD10, and cyclinD1 were used.
RESULTS
Six patients (4 female, and 2 male patients with a male/ female ratio of 1:2) with a mean age of 14 (min-max 13-16) years who were histopathologically diagnosed as SPT between 2010, and 2017 were included in the study. Admission complaint of 5 (88%) patients was abdominal pain. Abdominal ultrasound (US) performed with the indication of hirsutismus revealed the presence of a mass which established the diagnosis of SPT. The mass lesion was localized on the head (n=3; 50%), and tail (n=3; 50%) of the pancreas. US, and computed tomography (CT) were performed for the identification of the mass. All patients also additionally underwent magnetic resonance imaging (MRI). Median tumor diameter was 16.5 (5-10) cm. Liver function tests, cholestatic, and pancreatic enzymes were within normal limits The patients were followed up for a median of 71.5 (30-96) months. We performed Whipple surgery (n=3), distal pancreatectomy (n=1), distal pancreatectomy and splenectomy (n=1), and subtotal pancreatectomy (n=1).
Complication developed in one patient, and formation of a pseudocyst was also observed (Table 1) . Samples harvested from 6 patients were subjected to immunohistochemical analyses. In all patients beta-catenin, ceratin, CD56, vimentin CD 10 staining positivity was detected In one (16.3%) patient chromogranin, and in 3 (50%) patients synaptophysin positivity were detected ( Table 2) .
DISCUSSION
SPT is rarely seen in infants, and children, and constitutes 2-3% of all pancreatic tumors. Pediatric patients have a more improved prognosis when compared with adults [1] . Ten years ago very few studies were available on this subject. Standardization of terminology, and increase in the use of immunohistochemical staining, the level of awareness concerning these tumors has increased [8] . In a review performed with 292 patients with SPT median age of the patients at the time of the identification of the tumor was detected as 23.9 years with a male/ female ration of 1:9.4 [9] . In two separate studies performed on children, male/female ratios were found to be 1:27, and 1:2, respectively [8, 10] . In our study this ratio was 1:2, in compliance with the literature. SPT generally leads an asymptomatic course or causes inexplicit symptoms as abdominal pain, and distension. Therefore they are incidentally detected during physical examination or with imaging modalities [11] . Liver function test results, levels of cholestatic, and pancreatic enzymes, and serum tumor markers are usually within normal limits [12] . In these patients exocrine, and endocrinological insufficiency has not been detected up to now [13] . Our five cases presented with nonspecific complaints as abdominal pain, and only physical examination, and imaging modalities revealed this intraabdominal mass. In our one patient with hirsutismus, polycystic ovary syndrome, incidental abdominal US detected an intraabdominal mass. Liver function test results, cholestatic, and pancreatic enzymes, hormonal evaluation of the all patients were found to be within normal limits, and consistent with the diagnosis of polycystic ovary syndrome.
In the determination of pancreatic mass lesions, US is the first-line preference because of its lower cost, and lack of radiation exposure US may aid in the determination of the association of the mass with mesenteric, and splenic vessels, and Doppler US helps us to identify intratumoral vascularization [14] . Procacci et al. estimated diagnostic accuracy of CT in pancreatic tumors with cystic component as 60 percent. Although CT plays a major role in the diagnostic evaluation of cystic lesions of pancreas, when compared with MRI, some disadvantages of CT have been reported in demonstrating tissue characteristics as bleeding, cystic degeneration, and presence of a capsule [15, 16] . In our patients, firstly mass lesion was detected using US or CT, then MRI was used to make an initial radiological diagnosis of SPT (Fig. 1) .
In children tumor is more frequently (60-70%) localized on the head of the pancreas contrary to its location in adults, In children SPT is localized in the head of the pancreas. However in adult patients SPT is mostly (80%) localized in the body, and the tail of the pancreas [17] . In the present study, contary to literature findings mass lesion was located in the head of the pancreas in 50%, and in the tail of the pancreas also in 50% of the patients.
It has been reported that pancreatic SPT cells express exocrine, endocrine, mesenchymal, and epithelial cell markers in varying amounts [8] . SPT has a complex immune profile. In previous studies respective percentages of patients demonstrated positive staining with NSE (93%), vi- mentin (90%), chromogranin A, cytokeratin, and synaptophysin [2, 8] . In another study performed with 11 pediatric patients with SPT, respective percentages of patients displayed positive staining with NSE (36%), chromogranin A (91%) [8] . However in the present study only one patient (16.3%) manifested positive staining with chromogranin. In all patients, positive staining with beta-catenin, keratin, CD56, vimentin CD 10 was detected. Synaptophysin positivity was detected in 3 (50%) patients (Fig. 2) .
Surgical resection constitutes the basis of treatment.. In cases of radical resection of the tumor prognosis is generally good. Long-term survival, and recurrence rates were reported as 90, and 10%, respectively [18] . In 6 cases total surgical resection was achieved. Physical, and US examinations were maintained during follow-up period. During our average follow-up of 6 years any recurrence was not detected.
In conclusion, SPT is a rarely seen pancreatic mass with lower malignancy rates. Since it has nondescriptive characteristics, and asymptomatic course, diagnosis may be delayed. Survival rates are at a higher level when total surgical resection was performed. 
